1 - 25 of 37 results for author:"Greene W.C." in Literature citations
Results Customize
› Repeat search in UniProtKB (624)
| Role of retroviral restriction factors in the interferon-alpha-mediated suppression of HIV-1 in vivo. Pillai S.K., Abdel-Mohsen M., Guatelli J., Skasko M., Monto A., Fujimoto K., Yukl S., Greene W.C., Kovari H., Rauch A. et al. Proc. Natl. Acad. Sci. U.S.A. 109:3035-3040(2012) · UniProtKB (594) · Mapped (9) |
| Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Roan N.R., Muller J.A., Liu H., Chu S., Arnold F., Sturzel C.M., Walther P., Dong M., Witkowska H.E., Kirchhoff F. et al. Cell Host Microbe 10:541-550(2011) · Mapped (4) |
| Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. Arnold F., Schnell J., Zirafi O., Sturzel C., Meier C., Weil T., Standker L., Forssmann W.G., Roan N.R., Greene W.C. et al. J. Virol. 86:1244-1249(2012) · Mapped (4) |
| Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. Smith D.S., Guo K., Barrett B.S., Heilman K.J., Evans L.H., Hasenkrug K.J., Greene W.C., Santiago M.L. PLoS Pathog. 7:e1002284-e1002284(2011) · Mapped (22) |
| Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. Wissing S., Montano M., Garcia-Perez J.L., Moran J.V., Greene W.C. J. Biol. Chem. 286:36427-36437(2011) · Mapped (1) |
| Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. Santiago M.L., Smith D.S., Barrett B.S., Montano M., Benitez R.L., Pelanda R., Hasenkrug K.J., Greene W.C. J. Virol. 85:189-199(2011) · Mapped (21) |
| Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif. Lassen K.G., Wissing S., Lobritz M.A., Santiago M., Greene W.C. J. Biol. Chem. 285:29326-29335(2010) · Mapped (9) |
| Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. Santiago M.L., Benitez R.L., Montano M., Hasenkrug K.J., Greene W.C. J. Immunol. 185:1114-1123(2010) · Mapped (21) |
| HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors. Wissing S., Galloway N.L., Greene W.C. Mol. Aspects Med. 31:383-397(2010) · Mapped (17) |
| Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). Roan N.R., Sowinski S., Munch J., Kirchhoff F., Greene W.C. J. Biol. Chem. 285:1861-1869(2010) · UniProtKB (1) |
| APOBEC3G: an intracellular centurion. Chiu Y.L., Greene W.C. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 364:689-703(2009) · UniProtKB (1) |
| Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Santiago M.L., Montano M., Benitez R., Messer R.J., Yonemoto W., Chesebro B., Hasenkrug K.J., Greene W.C. |
| Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Kwon H.S., Brent M.M., Getachew R., Jayakumar P., Chen L.F., Schnolzer M., McBurney M.W., Marmorstein R., Greene W.C., Ott M. Cell Host Microbe 3:158-167(2008) · UniProtKB (1) · Mapped (6) |
| The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Chiu Y.L., Greene W.C. Annu. Rev. Immunol. 26:317-353(2008) · UniProtKB (11) |
| Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. Stopak K.S., Chiu Y.L., Kropp J., Grant R.M., Greene W.C. J. Biol. Chem. 282:3539-3546(2007) · Mapped (20) |
| High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Chiu Y.L., Witkowska H.E., Hall S.C., Santiago M., Soros V.B., Esnault C., Heidmann T., Greene W.C. Proc. Natl. Acad. Sci. U.S.A. 103:15588-15593(2006) · Mapped (4) |
| Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. Kreisberg J.F., Yonemoto W., Greene W.C. J. Exp. Med. 203:865-870(2006) · Mapped (12) |
| NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. Williams S.A., Chen L.F., Kwon H., Ruiz-Jarabo C.M., Verdin E., Greene W.C. EMBO J. 25:139-149(2006) · Mapped (9) |
| NF-kappaB RelA phosphorylation regulates RelA acetylation. Chen L.F., Williams S.A., Mu Y., Nakano H., Duerr J.M., Buckbinder L., Greene W.C. Mol. Cell. Biol. 25:7966-7975(2005) · UniProtKB (1) · Mapped (5) |
| p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. Bohuslav J., Chen L.F., Kwon H., Mu Y., Greene W.C. J. Biol. Chem. 279:26115-26125(2004) · Mapped (59) |
| Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65. O'Mahony A.M., Montano M., Van Beneden K., Chen L.F., Greene W.C. J. Biol. Chem. 279:18137-18145(2004) · Mapped (12) |
| HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Stopak K., de Noronha C., Yonemoto W., Greene W.C. |
| Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. Zander K., Sherman M.P., Tessmer U., Bruns K., Wray V., Prechtel A.T., Schubert E., Henklein P., Luban J., Neidleman J. et al. J. Biol. Chem. 278:43202-43213(2003) · Mapped (1) |
| Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. Chen L.F., Mu Y., Greene W.C. EMBO J. 21:6539-6548(2002) · UniProtKB (1) |
| Duration of nuclear NF-kappaB action regulated by reversible acetylation. Chen L.F., Fischle W., Verdin E., Greene W.C. |